Lupin forays into over-the-counter segment
Lupin has forayed into over-the-counter (OTC) segment in the country and plans to achieve Rs.300 crore turnover in the vertical in the next 5 years....
Tag : Lupin
Lupin Outlook for the Week (Jan 15, 2018 – Jan 19, 2018)
EquityPandit’s Outlook for Lupin for the week (Jan 15, 2018 – Jan 19, 2018) : LUPIN: Lupin closed the week on positive note gaining around 2.10%....
Lupin receives USFDA approval for Tamiflu Capsules
Lupin has received US health regulator’s approval for generic Tamiflu Capsules. The company stated that, it has received final approval for its Oseltamivir Phosphate Capsules...
Lupin Outlook for the Week (Jan 08, 2018 – Jan 12, 2018)
EquityPandit’s Outlook for Lupin for the week ( Jan 08, 2018 – Jan 12, 2018) : LUPIN: Lupin closed the week on positive note gaining around 1.70%. As...
Lupin introduces generic anti-infection capsules in US
Lupin for treating serious infections has launched Flucytosine capsules, in the American market. In a regulatory filing, Lupin stated that, the company has launched its...
Lupin Outlook for the Week (Jan 01, 2018 – Jan 05, 2018)
EquityPandit’s Outlook for Lupin for the week ( Jan 01, 2018 – Jan 05, 2018) : LUPIN: Lupin closed the week on positive note gaining around 1.50%....
Lupin gets USFDA nod for Calcipotriene Topical Solution
Lupin has received final approval for Calcipotriene Topical Solution, 0.005% (Scalp Solution), from USFDA. The company has received approval to market a generic version of Dovonex...
Lupin Outlook for the Week (Dec 26, 2017 – Dec 29, 2017)
EquityPandit’s Outlook for Lupin for the week (Dec 26, 2017 – Dec 29, 2017) : LUPIN: Lupin closed the week on positive note gaining...
Lupin Outlook for the Week (Dec 18, 2017 – Dec 22, 2017)
EquityPandit’s Outlook for Lupin for the week (Dec 18, 2017 – Dec 22, 2017) : LUPIN: Lupin closed the week on positive note gaining...
Lupin receives approval for Tydemy from USFDA
Lupin has received approval from the US health regulator, for Tydemy drug that is used to prevent pregnancy. The company has received final approval for its Tydemy (Drospirenone, Ethinyl...